Henan Lingrui Pharmaceutical Statistics

Total Valuation

Henan Lingrui Pharmaceutical has a market cap or net worth of CNY 12.00 billion. The enterprise value is 11.07 billion.

Market Cap	12.00B
Enterprise Value	11.07B

Important Dates

The next estimated earnings date is Saturday, April 26, 2025.

Earnings Date	Apr 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Henan Lingrui Pharmaceutical has 563.16 million shares outstanding. The number of shares has decreased by -0.51% in one year.

Current Share Class	n/a
Shares Outstanding	563.16M
Shares Change (YoY)	-0.51%
Shares Change (QoQ)	-2.78%
Owned by Insiders (%)	1.40%
Owned by Institutions (%)	24.19%
Float	433.43M

Valuation Ratios

The trailing PE ratio is 17.71 and the forward PE ratio is 17.33. Henan Lingrui Pharmaceutical's PEG ratio is 0.91.

PE Ratio	17.71
Forward PE	17.33
PS Ratio	3.35
PB Ratio	4.17
P/TBV Ratio	4.46
P/FCF Ratio	19.63
P/OCF Ratio	n/a
PEG Ratio	0.91

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.05, with an EV/FCF ratio of 18.12.

EV / Earnings	16.38
EV / Sales	3.11
EV / EBITDA	14.05
EV / EBIT	15.61
EV / FCF	18.12

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.01.

Current Ratio	1.18
Quick Ratio	0.94
Debt / Equity	0.01
Debt / EBITDA	0.03
Debt / FCF	0.03
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.05% and return on invested capital (ROIC) is 15.41%.

Return on Equity (ROE)	24.05%
Return on Assets (ROA)	9.31%
Return on Capital (ROIC)	15.41%
Revenue Per Employee	1.41M
Profits Per Employee	267,115
Employee Count	2,530
Asset Turnover	0.75
Inventory Turnover	2.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.51% in the last 52 weeks. The beta is 0.33, so Henan Lingrui Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	+25.51%
50-Day Moving Average	21.89
200-Day Moving Average	23.01
Relative Strength Index (RSI)	43.61
Average Volume (20 Days)	8,162,706

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Henan Lingrui Pharmaceutical had revenue of CNY 3.56 billion and earned 675.80 million in profits. Earnings per share was 1.20.

Revenue	3.56B
Gross Profit	2.62B
Operating Income	708.96M
Pretax Income	780.27M
Net Income	675.80M
EBITDA	785.89M
EBIT	708.96M
Earnings Per Share (EPS)	1.20

Full Income Statement

Balance Sheet

The company has 956.81 million in cash and 21.30 million in debt, giving a net cash position of 935.51 million or 1.66 per share.

Cash & Cash Equivalents	956.81M
Total Debt	21.30M
Net Cash	935.51M
Net Cash Per Share	1.66
Equity (Book Value)	2.90B
Book Value Per Share	5.10
Working Capital	344.07M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 654.79 million and capital expenditures -43.86 million, giving a free cash flow of 610.92 million.

Operating Cash Flow	654.79M
Capital Expenditures	-43.86M
Free Cash Flow	610.92M
FCF Per Share	1.08

Full Cash Flow Statement

Margins

Gross margin is 73.56%, with operating and profit margins of 19.89% and 18.96%.

Gross Margin	73.56%
Operating Margin	19.89%
Pretax Margin	21.89%
Profit Margin	18.96%
EBITDA Margin	22.05%
EBIT Margin	19.89%
FCF Margin	17.14%

Dividends & Yields

This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 3.81%.

Dividend Per Share	0.80
Dividend Yield	3.81%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	5
Payout Ratio	67.58%
Buyback Yield	0.51%
Shareholder Yield	4.33%
Earnings Yield	5.65%
FCF Yield	5.09%

Dividend Details

Stock Splits

The last stock split was on July 2, 2014. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 2, 2014
Split Type	Forward
Split Ratio	1.5

Scores

Henan Lingrui Pharmaceutical has an Altman Z-Score of 5.4.

Altman Z-Score	5.4
Piotroski F-Score	n/a